http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100735781-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 |
| filingDate | 2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100735781-B1 |
| titleOfInvention | Isoquinoline Compounds and Medical Uses thereof |
| abstract | The present invention relates to isoquinoline compounds represented by the following formula (I), optically active agents thereof, their pharmaceutically acceptable salts, their water adducts, hydrates and their solvates, and poly (ADP-ribose) containing the compound And a poly (ADP-ribose) synthetase inhibitor containing the compound, and a prophylactic and / or therapeutic agent for diseases caused by hyperfunction of the synthetase. The compounds are also useful as agents for preventing and / or treating cerebral infarction, in particular for preventing and / or treating acute cerebral infarction. It is also useful as a prophylactic and / or therapeutic agent for ameliorating neurological symptoms associated with cerebral infarction, particularly acute cerebral infarction.n n n Isoquinoline Compounds, Poly (ADP-Ribose) Synthetase Inhibitors, Cerebral Infarction |
| priorityDate | 2002-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.